You just read:

LKC Technologies' Clinical Trial Validates Cost-Effective Alternative to Gold Standard in Diabetic Retinopathy Screening. Details to be presented at EURETINA/ESCRS London

News provided by

LKC Technologies, Inc.

04 Sep, 2014, 11:00 BST